Trial Profile
A Phase I, Randomized, Single-blind, Placebo-controlled, Sequential-group, Single-center Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of AZD7594 Given Once Daily as Inhaled Formulation in Healthy Japanese Men
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Velsecorat (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors AstraZeneca
- 20 Jun 2016 Status changed from suspended to completed.
- 10 May 2016 Status changed from recruiting to suspended as study is on hold from 2016-04-06 until mid June, depending on the result of an amendment to study D3741C0004.)
- 19 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.